Taiwan aims to become a global precision health hub
Taiwan is pushing to turn its chip and health-data strengths into a new biotech industry, a potential win for its economy and for investors watching the island beyond semiconductors.
- Global medical spending is rising faster than the world economy as people get older, and is set to hit $15 trillion by 2030.
- Taiwan wants to combine its national health insurance records, gene databases and AI chips to build "precision health" — medicine tailored to each person.
- The plan calls for feeding health data into AI platforms without moving it out of hospitals, building medical chips, and training people who know both medicine and AI.
- The government just approved a 10-year, roughly $300 million investment program and is folding biotech into its wider AI push.
- Taiwan's biotech sector already pulled in $1.7 billion of investment last year and made about $25 billion in revenue.
Outlook: Expect more state money and policy changes aimed at building what officials call a "smart biotech national team," with semiconductor firms drawn into healthcare.